Changes in chemotherapy for pancreatic adenocarcinoma;Evolution de la chimiothérapie de l'adénocarcinome du pancréas

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 6-7, 2002, Pages 603-604

  Hammel, Pascal ^a,b  

^a BEAUJON HOSPITAL   (France)

^b Serv Gastroenterol   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN;

BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL PROTOCOL; CLINICAL RESEARCH; DRUG CHOICE; EDITORIAL; GASTROINTESTINAL TOXICITY; HUMAN; PANCREAS ADENOCARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FLUOROURACIL; HUMANS; LEUCOVORIN; PANCREATIC NEOPLASMS;

EID: 0036319909     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Chimiothérapie des adénocarcinomes du pancréas non résécables par 5-fluorouracile, acide folinique et cisplatine (LV5-FU2)
2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
3. Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: Final results of a GERCOR multicenter phase II study
4. Pancreatic cancer: The evolving role of systemic therapy
5. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: A prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale
6. Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer
7. Survie des malades ayant un adénocarcinome pancréatique non résécable: Les données de la littérature sont rendues caduques par les nouvelles modalités thérapeutiques
8. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine
9. Transcription of SST2 somatostatin receptor gene in human pancreatic cancer cells is altered by single nucleotide promoter polymorphism
10. Epidémiologie et pronostic des cancers du pancréas dans le département du Calvados: Tendances évolutives sur 20 ans
11. Traitement des sténoses malignes duodénales: La prothèse métallique mise en place sous contrôle endoscopique ou radiologique peut-elle remplacer la dérivation chirurgicale?
12. Pain management of pancreatic cancer